TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes ; volume:13 ; number:1 ; day:1 ; month:12 ; year:2016 ; pages:1-14 ; date:12.2016
Retrovirology ; 13, Heft 1 (1.12.2016), 1-14, 12.2016
- Creator
-
Hofmann, Henning
- Contributor
-
Vanwalscappel, Bénédicte
Bloch, Nicolin
Landau, Nathaniel R.
SpringerLink (Online service)
- DOI
-
10.1186/s12977-016-0316-3
- URN
-
urn:nbn:de:1111-201612205171
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hofmann, Henning
- Vanwalscappel, Bénédicte
- Bloch, Nicolin
- Landau, Nathaniel R.
- SpringerLink (Online service)
Other Objects (12)
Deoxyguanosine is a TLR7 agonist
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
TLR7 Ligation Inhibits TLR8 Responsiveness in IL-27-Primed Human THP-1 Monocytes and Macrophages
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
Non-thermal plasma treatment induces MAPK signaling in human monocytes
Deoxyguanosine is a TLR7 agonist
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
TLR7 Ligation Inhibits TLR8 Responsiveness in IL-27-Primed Human THP-1 Monocytes and Macrophages
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
Non-thermal plasma treatment induces MAPK signaling in human monocytes
Deoxyguanosine is a TLR7 agonist
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
TLR7 Ligation Inhibits TLR8 Responsiveness in IL-27-Primed Human THP-1 Monocytes and Macrophages
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination